Trillium Therapeutics Inc TRIL.TO :
* TRILLIUM THERAPEUTICS REPORTS SECOND QUARTER 2020 FINANCIAL AND OPERATING RESULTS
* TRILLIUM THERAPEUTICS- AS OF JUNE 30, HAD CASH AND CASH EQUIVALENTS AND MARKETABLE SECURITIES OF $130.8 MILLION, COMPARED TO $22.7 MILLION AT DEC 31, 2019